SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Arcturus Therapeutics Secures $50 Million Investment From Meiji Seika Pharma

Arcturus Therapeutics said it secured a $50 million investment from Meiji Seika Pharma in an expanded collaboration.

ARCT

Related stories